Creative Biolabs offers CellRapeutics™ cytotoxicity test for CAR-T cells.
CAR engrafted T cell or NK cell may be toxic to normal cells which also express some tumor associated antigens on cell surface, however, this possibility can be evaluated via cytotoxicity analysis. Meanwhile, as an efficient alternative strategy, we can also coexpress CARs with an appropriate suicide gene which can regulate this potential cytotoxicity, in order to kill the cancer cells without influencing the normal ones. Please contact us at any time. We are always here to assist you.
From immuno-oncology news website.
For any technical issues or products/services related questions, please leave your information below. Our team will contact you soon.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
Angiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE